<VariationArchive VariationID="643059" VariationName="NM_003721.4(RFXANK):c.419_438+38del" VariationType="Deletion" Accession="VCV000643059" Version="10" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-07-29" DateCreated="2019-08-14" MostRecentSubmission="2024-05-26">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="653023" VariationID="643059">
      <GeneList>
        <Gene Symbol="RFXANK" FullName="regulatory factor X associated ankyrin containing protein" GeneID="8625" HGNC_ID="HGNC:9987" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19p13.11</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="19192258" stop="19201866" display_start="19192258" display_stop="19201866" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="19303007" stop="19312677" display_start="19303007" display_stop="19312677" Strand="+" />
          </Location>
          <OMIM>603200</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_003721.4(RFXANK):c.419_438+38del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>19p13.11</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="19197599" stop="19197656" display_start="19197599" display_stop="19197656" variantLength="58" positionVCF="19197598" referenceAlleleVCF="ACCGTTCGCTTCCTGCTGGAGTGGGTGCGTCCCAGCCCAGCTGGGCAGCTGGGGGGTTC" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="19308408" stop="19308465" display_start="19308408" display_stop="19308465" variantLength="58" positionVCF="19308407" referenceAlleleVCF="ACCGTTCGCTTCCTGCTGGAGTGGGTGCGTCCCAGCCCAGCTGGGCAGCTGGGGGGTTC" alternateAlleleVCF="A" />
      </Location>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003721.3" sequenceAccession="NM_003721" sequenceVersion="3" change="c.419_438+38delTTCGCTTCCTGCTGGAGTGGGTGCGTCCCAGCCCAGCTGGGCAGCTGGGGGGTTCCCG">
            <Expression>NM_003721.3:c.419_438+38delTTCGCTTCCTGCTGGAGTGGGTGCGTCCCAGCCCAGCTGGGCAGCTGGGGGGTTCCCG</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.19197602_19197659del" Assembly="GRCh38">
            <Expression>NC_000019.10:g.19197602_19197659del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.19308411_19308468del" Assembly="GRCh37">
            <Expression>NC_000019.9:g.19308411_19308468del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007432.1" sequenceAccession="NG_007432" sequenceVersion="1" change="g.10404_10461del">
            <Expression>NG_007432.1:g.10404_10461del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003721.4" sequenceAccession="NM_003721" sequenceVersion="4" change="c.419_438+38del" MANESelect="true">
            <Expression>NM_003721.4:c.419_438+38del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001278727.2" sequenceAccession="NM_001278727" sequenceVersion="2" change="c.353_372+38del">
            <Expression>NM_001278727.2:c.353_372+38del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_134440.3" sequenceAccession="NM_134440" sequenceVersion="3" change="c.350_369+38del">
            <Expression>NM_134440.3:c.350_369+38del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001370235.1" sequenceAccession="NM_001370235" sequenceVersion="1" change="c.416_435+38del">
            <Expression>NM_001370235.1:c.416_435+38del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001370238.1" sequenceAccession="NM_001370238" sequenceVersion="1" change="c.419_438+38del">
            <Expression>NM_001370238.1:c.419_438+38del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001370233.1" sequenceAccession="NM_001370233" sequenceVersion="1" change="c.419_438+38del">
            <Expression>NM_001370233.1:c.419_438+38del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001370234.1" sequenceAccession="NM_001370234" sequenceVersion="1" change="c.353_372+38del">
            <Expression>NM_001370234.1:c.353_372+38del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001370237.1" sequenceAccession="NM_001370237" sequenceVersion="1" change="c.416_435+38del">
            <Expression>NM_001370237.1:c.416_435+38del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001370236.1" sequenceAccession="NM_001370236" sequenceVersion="1" change="c.416_435+38del">
            <Expression>NM_001370236.1:c.416_435+38del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001278728.2" sequenceAccession="NM_001278728" sequenceVersion="2" change="c.350_369+38del">
            <Expression>NM_001278728.2:c.350_369+38del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_102" sequenceAccession="LRG_102">
            <Expression>LRG_102:g.10404_10461del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="603200.0002" DB="OMIM" />
        <XRef Type="rs" ID="1568579997" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003721.4(RFXANK):c.419_438+38del AND RFXANK-related disorder" Accession="RCV003411751" Version="5">
        <ClassifiedConditionList TraitSetID="91094">
          <ClassifiedCondition>RFXANK-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-08" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_003721.4(RFXANK):c.419_438+38del AND MHC class II deficiency 2" Accession="RCV004576969" Version="1">
        <ClassifiedConditionList TraitSetID="1826">
          <ClassifiedCondition DB="MedGen" ID="C1859535">MHC class II deficiency 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1998-11-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_003721.4(RFXANK):c.419_438+38del AND MHC class II deficiency" Accession="RCV000796674" Version="6">
        <ClassifiedConditionList TraitSetID="6425">
          <ClassifiedCondition DB="MedGen" ID="C2931418">MHC class II deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-12-11" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-08" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2019-08-14" MostRecentSubmission="2024-05-26">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10803838</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16166641</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21908431</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9806546</ID>
        </Citation>
        <DescriptionHistory Dated="2022-10-15">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-10-15">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="1826" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="8785" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Bare lymphocyte syndrome, type II, complementation group B</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">MHC class II deficiency 2</ElementValue>
                <XRef ID="MONDO:0971013" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MHC2D2</ElementValue>
                <XRef Type="MIM" ID="620815" DB="OMIM" />
              </Symbol>
              <XRef ID="C1859535" DB="MedGen" />
              <XRef ID="MONDO:0971013" DB="MONDO" />
              <XRef Type="MIM" ID="620815" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="91094" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="71198" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">RFXANK-related disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">RFXANK-related condition</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="6425" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="486" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">BARE LYMPHOCYTE SYNDROME, TYPE II, COMPLEMENTATION GROUP A</ElementValue>
                <XRef Type="MIM" ID="209920" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">SCID, HLA CLASS II-NEGATIVE</ElementValue>
                <XRef Type="MIM" ID="209920" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Bare lymphocyte syndrome 2</ElementValue>
                <XRef ID="C537079" DB="MeSH" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">BLS 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Severe combined immunodeficiency, HLA class II negative</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">SCID, HLA Class 2-Negative</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">BLS, TYPE II</ElementValue>
                <XRef Type="MIM" ID="209920" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">MHC class II deficiency</ElementValue>
                <XRef ID="MONDO:0008855" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Bare Lymphocyte Syndrome</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="824" />
                <XRef ID="824" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="572" DB="Orphanet" />
              <XRef ID="C2931418" DB="MedGen" />
              <XRef ID="MONDO:0008855" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS209920" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="27173" SubmissionDate="2018-09-11" DateLastUpdated="2024-05-26" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="603200.0002_MHC CLASS II DEFICIENCY 2" title="RFXANK, 58-BP DEL_MHC CLASS II DEFICIENCY 2" />
        <ClinVarAccession Accession="SCV000027173" DateUpdated="2024-05-26" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1998-11-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In cell lines from a patient (BLS1) with MHC class II deficiency-2 (MHC2D2; 620815), Masternak et al. (1998) found a homozygous 58-bp deletion of genomic DNA that removed the last 23 nucleotides and the splice donor site of exon 6 of the RFXANK gene.</Attribute>
              <Citation>
                <ID Source="PubMed">9806546</ID>
              </Citation>
              <XRef DB="OMIM" ID="620815" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RFXANK" />
          </GeneList>
          <Name>RFXANK, 58-BP DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">58-BP DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="603200.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MHC CLASS II DEFICIENCY 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1830042" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2019-08-14">
        <ClinVarSubmissionID localKey="4728376|MedGen:C2931418" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000936197" DateUpdated="2024-02-14" DateCreated="2019-08-14" Type="SCV" Version="6" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-12-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10803838</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16166641</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21908431</ID>
          </Citation>
          <Comment>In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Loss-of-function variants in RFXANK are known to be pathogenic (PMID: 10803838, 16166641, 21908431). Experimental studies and prediction algorithms are not available for this variant, and the functional significance of the affected amino acid(s) is currently unknown. This variant has not been reported in the literature in individuals with RFXANK-related disease. ClinVar contains an entry for this variant (Variation ID: 643059). This variant is not present in population databases (ExAC no frequency). This variant is a deletion of the genomic region encompassing part of exon 6 (c.419_438+38del) of the RFXANK gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RFXANK" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000019.9:g.19308408_19308465del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2931418" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7683700" SubmissionDate="2024-03-08" DateLastUpdated="2024-03-16" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="19810701|RFXANK-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004106334" DateUpdated="2024-03-16" DateCreated="2023-11-20" Type="SCV" Version="2" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>The RFXANK c.419_438+38del58 variant is predicted to result in a deletion affecting a canonical splice site. This variant has been reported in individuals with major histocompatibility class II deficiency, also referred to as bare lymphocyte syndrome, complementation group B (Masternak et al. 1998. PubMed ID: 9806546; Supplemental Table 3, Farwell et al. 2014. PubMed ID: 25356970). This variant is reported in 0.0023% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Frameshift variants in RFXANK are expected to be pathogenic. This variant is interpreted as likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RFXANK" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003721.3:c.419_438+38del58</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">RFXANK-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13915440</SubmissionName>
          <SubmissionName>SUB14299258</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="27173" TraitType="Disease" MappingType="Name" MappingValue="MHC CLASS II DEFICIENCY 2" MappingRef="Preferred">
        <MedGen CUI="C1859535" Name="MHC class II deficiency 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7683700" TraitType="Disease" MappingType="Name" MappingValue="RFXANK-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="RFXANK-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1830042" TraitType="Disease" MappingType="XRef" MappingValue="C2931418" MappingRef="MedGen">
        <MedGen CUI="C2931418" Name="MHC class II deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

